Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma.

Golmohammadi M, Raza S, Albayyadhi M, Sholehrasa H, Khouri J, Williams L, Hansen DK, Moradi A, Xu X, Albliwi M, Ali AH, Dima D, Anwer F, Paul B, Jaberi-Douraki M

Open source

DOI
10.1038/s41408-025-01334-5
Published
2025 Aug 1
Container
Blood cancer journal
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41408-025-01334-5,
  title = {Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma.},
  author = {Golmohammadi M and Raza S and Albayyadhi M and Sholehrasa H and Khouri J and Williams L and Hansen DK and Moradi A and Xu X and Albliwi M and Ali AH and Dima D and Anwer F and Paul B and Jaberi-Douraki M},
  year = {2025},
  journal = {Blood cancer journal},
  doi = {10.1038/s41408-025-01334-5},
  url = {https://doi.org/10.1038/s41408-025-01334-5}
}

RIS

TY  - JOUR
TI  - Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma.
AU  - Golmohammadi M
AU  - Raza S
AU  - Albayyadhi M
AU  - Sholehrasa H
AU  - Khouri J
AU  - Williams L
AU  - Hansen DK
AU  - Moradi A
AU  - Xu X
AU  - Albliwi M
AU  - Ali AH
AU  - Dima D
AU  - Anwer F
AU  - Paul B
AU  - Jaberi-Douraki M
PY  - 2025
JO  - Blood cancer journal
DO  - 10.1038/s41408-025-01334-5
UR  - https://doi.org/10.1038/s41408-025-01334-5
ER  - 

APA

M, G., S, R., M, A., H, S., J, K., L, W., DK, H., A, M., X, X., M, A., AH, A., D, D., F, A., B, P., & M, J. (2025). Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma.. Blood cancer journal. https://doi.org/10.1038/s41408-025-01334-5

Source records